Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Articles

Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results

Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka-Sayama
Division of Hematology Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul
Hematology and Oncology, Tokai University Hospital, Isehara
Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka
Department of Hematology, National Cancer Center Hospital, Tokyo
Oncology Center, Gunma University Hospital, Maebashi
Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo
Hematology, International Medical Center, Saitama Medical University, Saitama
Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto
Department of Hematology, Juntendo University School of Medicine, Tokyo
Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto
Internal Medicine, Seoul National University Hospital, Seoul
Hematology and Oncology, Osaka University Graduate School of Medicine, Suita
Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya
Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National Medical School, Gwangju
Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima
Third Internal Medicine, Yamagata University Hospital, Yamagata
Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul
Hematology and Oncology, Konkuk University Medical Center, Seoul
Medical Oncology/Hematology, Kobe University Hospital, Kobe
Center for Hematologic Malignancy, National Cancer Center, Goyang-si
Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo
Division of Hematology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon
Division of Hematology-Oncology, Seoul National University Bundang Hospital, Gyeonggi
Internal Medicine, Inje University Busan Paik Hospital, Busan
Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya
Hematology and Oncology, Kyoto University Hospital, Kyoto
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
Hematology, National Hospital Organization Nagasaki Medical Center, Omura
HUYABIO International, San Diego, CA
Huya Japan GK, Tokyo
Department of Hematology, National Cancer Center Hospital, Tokyo
Haematologica Early view Jun 6, 2024 https://doi.org/10.3324/haematol.2023.283992

Abstract

Not available.

Figures & Tables

Article Information

Early view : Articles
 
DOI
https://doi.org/10.3324/haematol.2023.283992
 
Published
2024-06-06
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2024 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
385
PDF Downloads
179

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2024 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online